第十一节 其他症状量表
一、不安腿综合征评定量表（RLS-6）
不安腿综合征评定量表（RLS-6 Rating Scales，RLS-6）
请根据最近7个白天或夜晚的情况回答下列问题：
1.您对最近7个晚上的睡眠质量满意程度如何？
在最近7个夜晚或白天，您的不安腿综合征症状在下列情况时的严重程度如何？
2.睡眠时
3.在夜间
4.在白天休息时（坐位，卧位）
5.在白天未休息而从事活动时（步行、工作、做作业、闲暇活动）
6.在最近7个白天，您（从早晨起床到夜间就寝前）的疲劳或困倦程度如何？
二、国际不安腿综合征研究小组RLS严重程度量表（IRLS）
国际不安腿综合征研究小组RLS严重程度量表（The IRLSSG Rating Scale，IRLS）
请患者按照下列10个问题对其症状进行评分。由患者本人而非检查者进行评分，但检查者应能够就患者对问题的任何不理解之处进行解释。由检查者将患者的答案标记在表格上。
在刚过去的1周……
1.总体上，您对自己下肢或上肢的不安腿综合征不适症状如何评价？
极重度..............................4□
重度..............................3□
中度..............................2□
轻度..............................1□
无..............................0□
在刚过去的1周……
2.总体上，您对自己因不安腿综合征症状而需要走动如何评价？
极重度..............................4□
重度..............................3□
中度..............................2□
轻度..............................1□
无..............................0□
在刚过去的1周……
3.总体上，走动使您的上肢或下肢不安腿综合征症状缓解的程度如何？
无缓解.............................4□
轻度缓解.............................3□
中度缓解.............................2□
完全或几乎完全缓解.......................1□
无需要缓解的不安腿综合征症状...................0□
在刚过去的1周……
4.由于不安腿综合征的症状而导致您睡眠障碍的严重程度如何？
极重度..............................4□
重度..............................3□
中度..............................2□
轻度..............................1□
无..............................0□
在刚过去的1周……
5.由于不安腿综合征的症状而导致您白天疲倦或嗜睡的严重程度如何？
极重度..............................4□
重度..............................3□
中度..............................2□
轻度..............................1□
无..............................0□
在刚过去的1周……
6.您不安腿综合征的总体严重程度如何？
极重度..............................4□
重度..............................3□
中度..............................2□(www.xing528.com)
轻度..............................1□
无..............................0□
在刚过去的1周……
7.您不安腿综合征症状出现的频率如何？
非常常见（指每周有6~7d发生）...................4□
常见（指每周有4~5d发生）..................3□
有时（指每周有2~3d发生）...................2□
偶尔（指每周有1d发生）...................1□
从不..............................0□
在刚过去的1周……
8.当你出现不安腿综合征的症状时，其平均严重程度如何？
极重度（指每日24h中有8h或以上有症状）...............4□
重度（指每日24h中有3~8h有症状）...................3□
中度（指每日24h中有1~3h有症状）...................2□
轻度（指每日24h中有症状的时间小于1h）...............1□
荩IRLS总评分（1~10项单项记分的总和）_____________（仅有研究者计算）
1. Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Manual, North Tonawanda, NY: Multi-Health Systems Inc; 1999.（Copyright鬁1992, 1999. Muti-Health Systems Inc.）.
2.何燕玲，诸索宇，张明园译.阳性与阴性症状量表（中文版）手册（内部出版物）.
3. Alphs, et al. Selection and Validation of a 4-Item Negative Symptom Assessment (NSA-4): A Short, Practical Clinical Tool for the Assessment of Negative Symptoms, June 23, 2008.
4. Battaglia J, Lindborg S R, Alaka K, et al. Calming versus sedative effects of intramuscular olanzapine in agitated patients. Am J Emerg Med, 2003, 21(3): 192-198 (Copyright 1998, Eli Lilly and Company, all rights reserved).
5. Centorrino F, Meyers A L, Jonna Ahl, et al. An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia / schizoaffective disorder. Hum. Psychopharmacol Clin Exp, 2007, 22(7): 455-462.
6. Montgomery S A, Asberg M. A new depression scale designed to be sensitive to change. Brit J Psychiatry， 1979, 134 (4): 382-389.
7.张明园.精神科评定量表手册.长沙：湖南科学技术出版社, 1993, 122-130, 134-137, 186-189, 192-193.
8. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol, 1967, 6(4): 278-296.
9. Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res, 1990, 3(4): 247-251.
10. Rush A J, Trivedi M H, Ibrahim H M, et al. The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psycho-metric evaluation in patients with chronic major depression. Biol Psychiatry, 2003, 54(5): 573-583.
11. Beck A T, Kovacs M, Weissman A. Assessment of suicidal intention: the scale of suicide ideation. J Consult Clin Psychology, 1979, 47(2): 343-352.
12.李献云，费立鹏，童永胜，等. Beck自杀意念量表中文版在社会成年人群中应用的信效度.中国心理卫生杂志，2010, 24(4): 250-255.
13. Oquendo M A, Halberstam B, Mann J J. Risk factors for suicidal behavior: utility and limitations of research instruments. In M.B. First ［Ed.］ Standardized Evaluation in Clini-cal Practice, 2003, 103-130.
14. Lipman R S, Covi L, Downing R W, et al. Pharmacotherapy of anxiety and depression. Psychopharmacol Bull, 1981, 17(3): 91-103.
15. Lipman RS. Differentiating anxiety and depression in anxiety disorders: use of rating scale. Psychopharmacol Bull, 1982, 18(4): 69-77.
16. Hamilton M.The assessment of anxiety states by rating. Br J Med Psychol, 1959, 32(1): 50-55.
17. Zung W W. A rating instrument for anxiety disorders. Psychosomatics, 1971, 12(6): 371-379.
18.季建林.医学心理学.第4版.上海：复旦大学出版社，2005, 231, 234.
19. Zigmond A S, Snaith R P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand, 1983, 67 (6): 361-370.
20. Young R C, Biggs J T, Ziegler V E, Meyer D A. A rating scale for mania: reliability, va-lidity, and sensitivity. Br J Psychiatry, 1978, 133(11): 429-435.
21. Kay S R, Wolkenfeld F, Murrill L M. Profiles of aggression among psychiatric patients. I. Nature and prevalence. J Nerv Ment Dis, 1988, 176 (9): 539-546.
22. Goodman W K, Price L H, Rasmussen S A, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry, 1989a, 46(11): 1006-1011.
23. Hachinski V C, Lassen N A, Marshall J. Multi-infarct dementia: a cause of mental deteri-oration in the elderly. Lancet, 1974, 2: 207-210.
24. Folstein M F, Folstein S E, McHugh P R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res, 1975, 12(3): 189-198.
25. Rosen W G, Mohs R C, Davis K L. A new rating scale for Alzheimer,s disease. Am J Psychiatry, 1984, 141(11): 1356-1364.
26. Carlsson A M. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain, 1983, 16(1): 87-101.
27.肖卫东，刘平，赵靖平，等.睡眠障碍评定量表的信度和效度分析.中国心理卫生杂志, 2007, 21(1): 40-41.
28. Parrott A C, Hindmarch I. Factor analysis of a sleep evaluation questionnaire. Psycho-logical Medicine, 1978, 8(2): 325-329.
29. Parrott A C, Hindmarch I. The Leeds Sleep Evaluation Questionnaire in psychopharmaco-logical investigations—a review. Psychopharmacology, 1980, 71 (2): 173-179.
30. Folstein M F, Luria R. Reliability, validity, and clinical application of the Visual Ana-logue Mood Scale. Psychol Med, 1973, 3 (4): 479-486.
31. Monk T H. A visual analogue scale technique to measure global vigor and affect. Psychi-atry Res, 1989, 27(1): 89-99.
32. Harvey A G, Schmidt D A, Scarna A, et al. Sleep-related functioning in euthymic pa-tients with bipolar disorder, patients with insomia, and patients without sleep problems. American J Psychiatry, 2005, 162(1): 50-57.
33. McGahuey C A, Delgado P L, Glenberg A J. Assessment of sexual dysfunction using the Arizona Sexual Experiences Scale (ASEX) and implications for the treatment of depres-sion. Psychiatric Annals, 1999, 29: 39-45.
34. McGahuey C A, Gelenberg A J, Laukes C A, et al. The Arizona Sexual Experiences Scale(ASEX): reliability and validity. J Sex Marital Ther, 2000, 26 (1): 25-40.
35. Kohnen R, Oertel WH, Stiasny-Kolster K, et al. Severity rating of Restless Legs Syn-drome: Review of ten years experience with the RLS-6 scales in clinical trials. American Professional Sleep Societies (APSS). Sleep, 2003, 15: A342.
36. Walters A S, LeBrocq C, Dhar A, et al. International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med, 2003, 4 (2): 121-132.
免责声明：以上内容源自网络，版权归原作者所有，如有侵犯您的原创版权请告知，我们将尽快删除相关内容。
